Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
1990s
|
| gptkbp:brand |
gptkb:Cryselle
|
| gptkbp:care_instructions |
take at the same time each day
|
| gptkbp:class |
combination oral contraceptive
|
| gptkbp:clinical_trial |
studied for safety and efficacy
|
| gptkbp:contraindication |
certain cancers
history of blood clots smoking over age 35 |
| gptkbp:dosage_form |
take as soon as remembered
0.3 mg norgestrel and 0.03 mg ethinyl estradiol if missed for 2 days, use backup contraception |
| gptkbp:effective_date |
FDA approved
|
| gptkbp:form |
oral tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cryselle
|
| gptkbp:ingredients |
gptkb:norgestrel
gptkb:ethinyl_estradiol |
| gptkbp:interacts_with |
antibiotics
anticonvulsants HIV medications |
| gptkbp:is_effective_against |
over 99% with perfect use
91% with typical use |
| gptkbp:is_used_for |
contraception
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:marketed_as |
gptkb:Europe
gptkb:Australia gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:packaging |
blister pack
|
| gptkbp:population |
consult healthcare provider
|
| gptkbp:previous_name |
norgestrel and ethinyl estradiol
|
| gptkbp:price |
varies by pharmacy
|
| gptkbp:regulates |
taken daily
|
| gptkbp:requires |
gptkb:theorem
|
| gptkbp:research |
ongoing for long-term effects
|
| gptkbp:scholarships |
available through manufacturer
|
| gptkbp:shelf_life |
check packaging
|
| gptkbp:side_effect |
gptkb:historical_event
headache nausea hypertension weight gain breast tenderness mood changes gallbladder disease liver tumors thromboembolic disorders |
| gptkbp:storage |
room temperature
|
| gptkbp:symptoms |
irregular periods
amenorrhea return of fertility |
| gptkbp:type_of_insurance |
may be covered by insurance
|
| gptkbp:bfsParent |
gptkb:norgestimate
|
| gptkbp:bfsLayer |
5
|